COMPOSITION:

Each film-coated sustained release tablet contains:
Acebrophylline ……….200 mg

Acebrophylline is a xanthine derivative and is primarily used as a bronchodilator in the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD) in adults.

MECHANISM OF ACTION:
Mucus Modification: Acebrophylline alters the mucus gel secretion phase by reducing its viscosity and increasing the serous gel phase. This makes mucus less sticky and easier to clear.

Ciliary Motility: It enhances the movement of the cilia (tiny hair-like structures in the respiratory tract), which helps in clearing mucus from the airways more efficiently.

Mucociliary Clearance: By improving ciliary motility and modifying mucus properties, Acebrophylline increases mucociliary clearance, thereby helping to keep the airways clear of mucus.

USES:
Bronchial Asthma: Helps in reducing symptoms and improving breathing.

COPD: Aids in managing symptoms and enhancing the quality of life for individuals with chronic obstructive pulmonary disease.

ADMINISTRATION:
Typically administered orally in tablet form. Dosage and frequency should be as prescribed by a healthcare provider, based on individual patient needs.

DISCLAIMER: All content published online is for informational purposes only. It is not intended to be a substitute for professional medical advice. Always seek the guidance of your doctor with any questions you may have regarding your health, medical condition, or any medicines.